Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Milsaperidone · 1 trial · 1 indication
The MADRS is a clinician-rated 10 item scale. Individual item scores are summed for a total possible score of 0 to 60 with a higher score indicating increased severity of depressive symptoms.
| Arm | Type | Description |
|---|---|---|
| Milsaperidone | EXPERIMENTAL | - |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Milsaperidone | DRUG | Oral milsaperidone |
| Placebo | DRUG | Oral placebo |
Inclusion Criteria: * Male or female patient 18 to 65 years of age, inclusive; * Meets DSM-5-TR criteria for MDD * Currently having an inadequate response to antidepressant therapy as confirmed by the Investigator using the Antidepressant Treatment Response Questionnaire (ATRQ) Exclusion Criteria:...
Top 20 of 32 competitors